In addition, SPOP inhibits the self-renewal and stem-like characteristics of PCa via the ubiquitin-dependent degradation of NANOG [24] in parallel with the fact that the mutation frequency of SPOP gene is up to 15% in PCa with poor prognosis [25]. The gene discussed is SPOP; the disease is posterior cortical atrophy.